Skip to main navigation Skip to search Skip to main content

Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy

M. Garcia-Montojo, S. Fathi, G. Norato, B. R. Smith, D. B. Rowe, M. C. Kiernan, S. Vucic, S. Mathers, R. P. A. van Eijk, U. Santamaria, M. L. Rogers, A. Malaspina, V. Lombardi, P. R. Mehta, H. J. Westeneng, L. H. van den Berg, A. Al-Chalabi, J. Gold, A. Nath*

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy'. Together they form a unique fingerprint.
    Sort by

    Pharmacology, Toxicology and Pharmaceutical Science

    Neuroscience